Ronald A. Cantrell
Genentech
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Ronald A. Cantrell.
JAMA Ophthalmology | 2017
Jeffrey R. Willis; Quan V. Doan; Michelle Gleeson; Zdenka Haskova; Pradeep Y. Ramulu; Lawrence S. Morse; Ronald A. Cantrell
Importance Among adults with diabetes in the United States, severe forms of diabetic retinopathy (DR) are significantly associated with a greater vision-related functional burden. Objective To assess the functional burden of DR across severity levels in the United States. Design, Setting, and Participants This cross-sectional study was based on 1004 participants 40 years or older with diabetes and valid ocular and sociodemographic outcomes in the National Health and Nutrition Examination Surveys (NHANES) (2005-2006 and 2007-2008). Diabetic retinopathy was based on fundus photograph grading, using the Early Treatment Diabetic Retinopathy Study severity scale. The analysis was performed from October 15, 2016, to June 15, 2017. Main Outcomes and Measures Functional difficulties secondary to vision were assessed during a household questionnaire in which participants self-reported difficulty with reading, visuospatial tasks (ie, close-up work or finding things on a crowded shelf), mobility (ie, walking down steps, stairs, or curbs), and driving. The main outcome measure was vision-related functional burden, which was defined as present for individuals reporting moderate or greater difficulty in any of the aforementioned tasks. Results Of the 1004 persons with diabetes analyzed for this study (mean age, 65.7 years [95% CI, 64.0-67.3 years]; 51.1% male [95% CI, 47.1-55.2] and 48.9% female [95% CI, 44.8-52.9]), the prevalence was 72.3% for no retinopathy, 25.4% for mild and moderate nonproliferative diabetic retinopathy (NPDR), and 2.3% for severe NPDR or proliferative diabetic retinopathy (PDR). The prevalence of vision-related functional burden was 20.2% (95% CI, 16.3%-24.1%) for those with no retinopathy, 20.4% (95% CI, 15.3%-27.8%) for those with mild and moderate NPDR, and 48.5% (95% CI, 25.6%-71.5%) for those with severe NPDR or PDR (P = .02). In multivariable analysis, the odds of vision-related functional burden were significantly greater among those with severe NPDR or PDR relative to those with no retinopathy (adjusted odds ratio [aOR], 3.59; 95% CI, 1.29-10.05; P = .02). Those with severe NPDR or PDR did not have a statistically significant greater odds of vision-related functional burden than did those with mild or moderate NPDR (aOR, 2.70; 95% CI, 0.93-7.78; P = .07). Conclusions and Relevance Among US adults with diabetes, approximately half of those with severe NPDR or PDR had difficulty with at least one visual function task. Moreover, vision-related functional burden was significantly greater among those with severe NPDR or PDR than among those with no retinopathy. These data suggest the importance of preventing severe forms of DR to mitigate the vision-related functional burden among US adults with diabetes. Future studies should complement our study by assessing the association of worsening retinopathy with objectively measured functional outcomes.
Ophthalmic Epidemiology | 2018
Jeffrey R. Willis; Quan V. Doan; Michelle Gleeson; Zdenka Haskova; Pradeep Y. Ramulu; Lawrence S. Morse; Ronald A. Cantrell
ABSTRACT Purpose: To assess healthcare utilization patterns across diabetic retinopathy (DR) severity levels in the United States (US). Design: Cross-sectional study of 699 adults, participating in the 2005–2008 National Health and Nutritional Examination Surveys. Methods: Diagnosis of DR was based on fundus photographs and categorized as: (1) no DR; (2) mild/moderate nonproliferative DR (NPDR); and (3) severe NPDR/proliferative DR (PDR). Healthcare utilization patterns were assessed during a household questionnaire where survey participants self-reported: (1) awareness that diabetes had affected their eyes; (2) pupil-dilation during the past year; and (3) visits to a diabetes education/nutrition specialist during the past year. Results: Among adults with self-reported diabetes, the proportion of those that were aware that diabetes had affected their eye was 15.3% [95% confidence interval (C.I.)] 10.9–19.6%), 21.7% (95% C.I. 14.6–28.7%), and 81.5% (95% C.I. 66.5–96.5%) across those with no retinopathy, mild/moderate NPDR, and severe NPDR/PDR, respectively (p < 0.01). The utilization of a diabetic education/nutrition specialist during the past year was 30.4% (95% C.I. 24.8–36.0%), 31.8% (95% C.I 23.4–40.2%), and 55.9% (95% C.I. 32.3–79.6%) across those with no retinopathy, mild/moderate NPDR, and severe NPDR/PDR, respectively (p = 0.13). Pupil dilation within the past year was 62.2% (95% C.I. 56.3–68.1%), 62.1% (95% C.I. 53.4–70.8%), and 93.8% (95% C.I. 87.3–100.0%) across those with no DR, mild/moderate NPDR, and severe NPDR/PDR, respectively (p = 0.01). Conclusions: Adults with diabetes in the United States, even those with the most severe forms of DR, do not fully utilize healthcare services for diabetic eye disease. Future studies should aim to address barriers to appropriate diabetes care.
Ophthalmology | 2016
Jeffrey R. Willis; Susan Vitale; Lawrence S. Morse; David W. Parke; William L. Rich; Flora Lum; Ronald A. Cantrell
Ophthalmology | 2017
Jeffrey R. Willis; Lawrence S. Morse; Susan Vitale; David W. Parke; William L. Rich; Flora Lum; Ronald A. Cantrell
Ophthalmology Retina | 2018
Pravin U. Dugel; Natasha Singh; Steven Francom; Ronald A. Cantrell; Susanna M. Grzeschik; Anne E. Fung
Ophthalmology | 2018
Usha Chakravarthy; Clare Bailey; R L Johnston; M McKibbin; Rehna Khan; Sajjad Mahmood; Louise Downey; Narendra Dhingra; Christopher Brand; Christopher Brittain; Jeffrey R. Willis; Sarah Rabhi; Anushini Muthutantri; Ronald A. Cantrell
JAMA Ophthalmology | 2018
Jeffrey R. Willis; Quan V. Doan; Ronald A. Cantrell
Investigative Ophthalmology & Visual Science | 2017
Brandon G. Busbee; Jordi Monés; Charles C. Wykoff; Giovanni Staurenghi; Fan Tang; Barbara Tong; Ronald A. Cantrell; Christopher Brittain; Jason S. Ehrlich; Hugh Lin; Nancy M. Holekamp
Investigative Ophthalmology & Visual Science | 2017
Usha Chakravarthy; Clare Bailey; Martin McKibbin; Sarah Rabhi; Anushini Muthutantri; Christopher Brittain; Jeffrey R. Willis; Ronald A. Cantrell
Investigative Ophthalmology & Visual Science | 2017
Jeffrey R. Willis; Quan Doan; Michelle Gleason; Lawrence S. Morse; Pradeep Y. Ramulu; Ronald A. Cantrell